Welcome to LookChem.com Sign In|Join Free
  • or
3-DEAZA-2'-DEOXYADENOSINE is a chemical compound that is structurally similar to adenosine, a nucleoside found in DNA and RNA. It is unique due to the absence of a nitrogen atom at the position typically occupied by the nitrogenous base in adenosine, which may confer distinct biological and pharmacological properties. This modification has garnered interest in its potential applications in antiviral therapy, as a research probe, and in the treatment of cancer and other diseases.

78582-17-9

Post Buying Request

78582-17-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

78582-17-9 Usage

Uses

Used in Antiviral Applications:
3-DEAZA-2'-DEOXYADENOSINE is used as an antiviral agent for its potential to inhibit viral replication and activity, offering a novel approach to combat viral infections.
Used in Research:
3-DEAZA-2'-DEOXYADENOSINE is used as a research probe to investigate the function of adenosine in biological systems, aiding in the understanding of adenosine's role in various physiological processes.
Used in Oncology:
3-DEAZA-2'-DEOXYADENOSINE is used as a potential therapeutic agent in oncology for its potential role in treating cancer, with ongoing research exploring its efficacy and mechanisms in combating cancer cells.
Used in Medical and Scientific Fields:
3-DEAZA-2'-DEOXYADENOSINE is used in the broader medical and scientific fields for its potential applications in treating various diseases, with further research being conducted to fully explore its capabilities and optimize its use.

Check Digit Verification of cas no

The CAS Registry Mumber 78582-17-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,5,8 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 78582-17:
(7*7)+(6*8)+(5*5)+(4*8)+(3*2)+(2*1)+(1*7)=169
169 % 10 = 9
So 78582-17-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N4O3/c12-11-10-6(1-2-13-11)15(5-14-10)9-3-7(17)8(4-16)18-9/h1-2,5,7-9,16-17H,3-4H2,(H2,12,13)/t7-,8+,9+/m0/s1

78582-17-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R,3S,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-2-(hydroxymethyl)oxolan-3-ol

1.2 Other means of identification

Product number -
Other names 2'-Deoxy-3-deazaadenosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:78582-17-9 SDS

78582-17-9Relevant academic research and scientific papers

Synthesis and Anti-herpetic Activity of Phosphoramidate ProTides

Maiti, Munmun,Persoons, Leentje,Andrei, Graciela,Snoeck, Robert,Balzarini, Jan,Herdewijn, Piet

, p. 985 - 993 (2013/07/27)

Among the many prodrug approaches aimed at delivering nucleoside monophosphates into cells, the phosphoramidate ProTide approach is one that has shown success, which has made it possible for some of the phosphoramidates to enter into clinical trials. Herein, we report the synthesis and antiviral activity of a series of phosphoramidate ProTides designed to bypass the thymidine kinase (TK) dependence of the parent nucleoside analogues. Phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) that contain L-alanine or pivaloyloxymethyl iminodiacetate (IDA-POM) exhibit anti-HSV-1 and anti-VZV activity in cell cultures, but they largely lost antiviral potency against TK-deficient virus strains. Among deazapurine nucleosides and their phosphoramidate derivatives, the 7-deazaadenine containing nucleosides and their phosphoramidate triester derivatives showed weak antiviral activity against VZV. Apparently, intracellular nucleotide delivery with these phosphoramidates is partly successful. However, none of the compound prodrugs showed superior activity to their parent drugs. Copyright

Nucleosides and nucleotides. 143. Synthesis of 5-amino-4- imidazolecarboxamide (AICA) deoxyribosides from deoxyinosines and their conversion into 3-deazapurine derivatives

Minakawa,Sasabuchi,Kiyosue,Kojima,Matsuda

, p. 288 - 295 (2007/10/03)

An efficient and large scale chemical synthesis of 5-aminoimidazole-4- carboxamide (AICA) 2'-deoxyriboside (5a) and its 3'-deoxyriboside 5b is described. Treatment of 3',5'-di-O-acetyl-N1-triphenylmethyl-2'-deoxyinosine (3a) with 5N NaOH in EtOH, followed by anhydrous trifluoroacetic acid gave 5a in 59% yield from 2'-deoxyinosine (1a). AICA 3'-deoxyriboside (5b) was also obtained in a similar manner as for 5a in 73% yield from 3'-deoxyinosine (1b). Conversion of these AICA derivatives (5a, b) into 3-deazapurine derivatives (9a, b, 15a, b, 20a, b) is also described.

SYNTHESIS OF 2-DEOXY-β-D-RIBONUCLEOSIDES AND2,3-DIDEOXY.β-D-PENTOFURANOSIDES ON IMMOBILIZED BACTERIAL CELLS

Votruba, Ivan,Holy, Antonin,Dvorakova, Hana,Guenter, Jaroslav,Hockova, Dana,et al.

, p. 2303 - 2330 (2007/10/02)

Alginate gel-entrapped cells of auxotrophic thymine-dependent strain of E. coli catalyze the transfer of 2-deoxy-D-ribofuranosyl moiety of 2'-deoxyuridine to purine and pyrimidine bases as well as their aza and deaza analogs.All experiments invariably gave β-anomers; in most cases, the reaction was regiospecific, affording N9-isomers in the purine and N1-isomers in the pyrimidine series.Also a 2,3-dideoxynucleoside can serve as donor of the glycosyl moiety.The acceptor activity of purine bases depends only little on substitution, the only condition being the presence of N7-nitrogen atom.On the other hand, in the pyrimidine series the activity is limited to only a narrow choice of mostly short 5-alkyl and 5-halogeno uracil derivatives.Heterocyclic bases containing amino groups are deaminated; this can be avoided by conversion of the base to the corresponding N-dimethylaminomethylene derivative which is then ammonolyzed.The method was verified by isolation of 9-(2-deoxy-β-D-ribofuranosyl) derivatives of adenine, guanine, 2-chloroadenine, 6-methylpurine, 8-azaadenine, 8-azaguanine, 1-deazaadenine, 3-deazaadenine, 1-(2-deoxy-β-D-ribofuranosyl) derivatives of 5-ethyluracil, 5-fluorouracil, and 9-(2,3-deoxy-β-D-pentofuranosyl)hypoxanthine, 9-(2,3-deoxy-β-D-pentofuranosyl)-6-methylpurine, and other nucleosides.

3-Deaza-2'-deoxyadenosine: Synthesis via 4-(Methylthio)-1H-imidazopyridine 2'-Deoxyribonucleosides and Properties of Oligonucleotides

Seela, Frank,Grein, Thomas,Samnick, Samuel

, p. 1639 - 1650 (2007/10/02)

The synthesis of 4-(methylthio)-1H-imidazopyridine 2'-deoxy-β-D-ribonucleosides 2 and 9 and the conversion of the N1-isomer 2 into the 2',3'-didehydro-2',3'-dideoxyribonucleoside 3a or (via 7) 3-deaza-2'-deoxyadenosine (1) is described.P

Imidazo[4,5-c]pyridines (3-deazapurines) and their nucleosides as immunosuppressive and antiinflammatory agents

Krenitsky,Rideout,Chao,Koszalka,Gurney,Crouch,Cohn,Wolberg,Vinegar

, p. 138 - 143 (2007/10/02)

A variety of imidazo[4,5-c]pyridines (3-deazapurines) were synthesized. With use of these aglycons as pentosyl acceptors, the corresponding ribonucleosides and 2'-deoxyribonucleosides were prepared by an enzymatic method involving transfer of the pentosyl moiety from appropriate pyrimidine nucleosides. With most of the imidazo[4,5-c]pyridines, the products obtained from the enzyme-catalyzed reactions were pentosylated exclusively in the 1-position. However, some 3-pentosylation occurred with aglycons that had H or N3 in the 4-position. In addition to the 2'-deoxy congener of the ribonucleoside of 4-amino-1H-imidazo[4,5-c]pyridine, the 5'-deoxy and 2',5'-dideoxy congeners were synthesized. All of the aglycons and their nucleosides were tested for toxicity to mammalian cells in culture. None were markedly cytotoxic. These compounds were also evaluated for their ability to inhibit lymphocyte-mediated cytolysis in vitro. 3-Deazaadenosine and its 2'-deoxy congener were the most potent inhibitors (ED50 = 20 μM). In addition to these two in vitro tests, in vivo inhibition of the inflammatory response in the rat carrageenan pleurisy model was determined. 3-Deazaadenosine was the most potent compound (ED50 = 3 mg/kg) in this in vivo test.

Anti-inflammatory deoxyribosides

-

, (2008/06/13)

The novel compounds 3-deaza-2'-deoxyadenosine and certain of its derivatives and their pharmaceutically acceptable salts have anti-inflammatory activity as well as immune response suppression activity. 3-Deaza-2'-deoxyadenosine and certain of its intermed

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 78582-17-9